URL details: www.opdivogastroeso.com/adjuvant-EC-GEJC-efficacy

URL title: OPDIVO® (nivolumab) Efficacy Data for the Adjuvant Treatment of ESO and GEJ Cancers
URL description: View efficacy information for OPDIVO® (nivolumab) for the adjuvant treatment of completely resected ESO or GEJ cancer. Please see Indications and Important Safety Information.
URL last crawled: 2023-01-04
URL speed: 0.475 MB/s, downloaded in 0.400 seconds

open external url

4 external links to this url

Only links from external domains are shown on this page.

found date
link text
from url
2022-09-14
Adjuvant Treatment of Completely Resected ESO or GEJ Cancer
2022-08-31
Adjuvant Treatment of Completely Resected ESO or GEJ Cancer
2022-07-22
Adjuvant Treatment of Completely Resected ESO or GEJ Cancer
2022-07-18
Adjuvant Treatment of Completely Resected ESO or GEJ Cancer